Trillions of bacteria live in the human gut without triggering an immune response. Scientists at St. Jude Children's Research Hospital have now discovered a gene-regulatory pathway that helps maintain this delicate balance. In a study published in Science Advances, they show that regulatory T cells, a type of immune cell, co-opt a well-known general gene expression pathway called COMPASS to suppress inappropriate immune responses and prevent lethal inflammation and autoimmunity.
COMPASS Pathway: A Key to Preventing Autoimmune Responses to Gut Bacteria
Researchers at St. Jude Children's Research Hospital have identified a gene-regulatory pathway called COMPASS that helps regulatory T cells prevent harmful immune responses to gut bacteria. This discovery is significant for understanding autoimmune diseases, which can have implications for healthcare in Iran. The findings highlight the importance of immune regulation in maintaining health.
👥 Key Players
📰 What Happened
Researchers discovered a gene-regulatory pathway called COMPASS that helps regulatory T cells manage immune responses to gut bacteria, preventing harmful inflammation and autoimmunity.
- The COMPASS pathway is crucial for maintaining immune balance in the gut.
- This discovery could lead to new treatments for autoimmune diseases.
💡 Why It Matters
📚 Background
Autoimmune diseases occur when the immune system mistakenly attacks the body's own cells, and understanding immune regulation is critical for developing effective treatments.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%